Back to UBS Group AG UBS Group AG

SGMTSGMT
12 quarters

Position history for UBS Group AGUBS Group AG's holdings in SAGIMET BIOSCIENCES INC

Yes. Ubs holds 339,930 shares of SGMT (Sagimet Biosciences), worth $2.6M, as of its Q2 2026 13F filing. It increased the position by 45,996 shares (+15.7%) from Q1 2026. Ubs has held SGMT in every 13F on record since Q3 2023, 12 quarterly filings.

Current Value

$2.6M

Current Shares

339,930

Total Value Change

+$2.6M

Total Shares Change

+336,939

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
339,930
+15.7%
$2.6M0.0%$7.73
30
2026-Q1
Increased
293,934
+45.7%
$1.5M0.0%$5.62
35
2025-Q4
Decreased
201,759
-34.2%
$1.2M0.0%$5.85
0
2025-Q3
Decreased
306,766
-46.4%
$2.1M0.0%$6.92
0
2025-Q2
Increased
572,735
+19.7%
$4.4M0.0%$7.87
32
2025-Q1
Increased
478,430
+43.6%
$1.6M0.0%$3.71
34
2024-Q4
Increased
333,160
+135.8%
$1.5M0.0%$4.72
41
2024-Q3
Increased
141,265
+46.6%
$391,3040.0%$2.82
32
2024-Q2
Increased
96,372
+52.6%
$329,5920.0%$3.42
33
2024-Q1
Increased
63,136
+215.9%
$342,1970.0%$5.42
38
2023-Q4
Increased
19,988
+568.3%
$108,3350.0%$5.42
24
2023-Q3
New
2,991
-
$26,3210.0%$8.80
29

Other major holders of SGMT: BlackRock, Inc., BALYASNY ASSET MANAGEMENT L.P., FMR LLC, Woodline Partners LP, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used